Why the study?
Do Exhaled Breath Acetone (EBA) levels predict cardiac and overall mortality in chronic heart failure patients?
Do Exhaled Breath Acetone (EBA) levels predict cardiac and overall mortality in chronic heart failure patients?
Exhaled breath acetone levels reflect right heart failure symptoms and serve as an independent predictor of mortality in chronic heart failure.
EBA may support noninvasive risk stratification in chronic HF; leaves open its incremental value and need for prospective validation.
This study shows that EBA levels reflect clinical HF features, especially right HF signs/symptoms. EBA is an independent predictor of cardiac and overall mortality in chronic HF patients.
No takes yet. Share an insight, caveat, or question.
Marcondes‐Braga et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: